PC
AEON icon

Periscope Capital’s AEON Biopharma AEON Stock Holding History

Periscope Capital’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,083
Closed -$1.58M – 611
2023
Q2 		$1.58M Hold
2,083
– – 0.12% 244
2023
Q1 		$1.52M Sell
2,083
-7,086
-77% -$5.14M 0.07% 310
2022
Q4 		$6.64M Sell
9,169
-2,587
-22% -$1.85M 0.29% 125
2022
Q3 		$8.34M Buy
11,756
+350
+3% +$248K 0.24% 147
2022
Q2 		$8.06M Buy
11,406
+696
+6% +$491K 0.22% 155
2022
Q1 		$7.54M Buy
10,710
+228
+2% +$160K 0.19% 179
2021
Q4 		$7.33M Buy
10,482
+3,556
+51% +$2.5M 0.2% 192
2021
Q3 		$4.86M Sell
6,926
-3
-0% -$2.1K 0.14% 289
2021
Q2 		$4.81M Buy
+6,929
New +$4.84M 0.16% 275

Other funds holding AEON

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Periscope Capital's AEON Position: Q3 2023 in Review

Periscope Capital sold out of AEON Biopharma (AEON) in Q3 2023, closing a stake of 2,083 shares — an estimated $1.58M sold.

Periscope Capital first reported a position in AEON in Q2 2021 and held it in 9 quarters. The position peaked at $8.34M in Q3 2022. 15 funds tracked by Wall St. Rank hold AEON as of Q3 2023.

  • Periscope Capital reported no remaining AEON Biopharma position as of Q3 2023 after selling out during the quarter.
  • Periscope Capital sold 2,083 AEON Biopharma shares in Q3 2023, an estimated $1.58M.
  • Periscope Capital first reported a position in AEON Biopharma in Q2 2021 and held it in 9 quarters.
  • Periscope Capital's AEON Biopharma position peaked at $8.34M in Q3 2022.
  • 15 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2023.

Based on Periscope Capital's 13F filing for Q3 2023, filed 6 Nov 2023.